HeartBeam initiated with a Buy at D. Boral Capital

D. Boral Capital initiated coverage of HeartBeam (BEAT) with a Buy rating and $5 price target The company’s novel ambulatory electrocardiogram platform aims to replicate the diagnostic capability of a standard 12-lead ECG using a compact patient-operated device, notes the analyst, who view remote patient monitoring as a “multi-billion-dollar opportunity.”